Ducommun unveils VISION 2032 plan targeting $300m-$500m acquisitions

The US aerospace and defence supplier sets mid-teens CAGR targets for missiles and radar as it scales its acquisition ambition fivefold.

A clean, brightly lit factory floor features robotic arms assembling jet engines on stands, with an aircraft fuselage and an overhead crane in the background.

Ducommun Incorporated, the California-based structural and electronic systems manufacturer serving the aerospace, defence and space sectors, used its first Investor Day in nearly four years to launch VISION 2032, an ambitious six-year roadmap that significantly widens the company's acquisition scope and ties its fortunes explicitly to the resurgence of US missile production and commercial aviation recovery.

Chairman and CEO Stephen Oswald confirmed that its current five-year plan, VISION 2027 announced in December 2022, is on track to meet or exceed all three headline financial targets: revenues reaching approximately $950 million by 2027, adjusted EBITDA margins expanding to roughly 18%, and higher-margin Engineered Products rising to approximately 25% of total revenue. Since the end of 2022, the company reports a total shareholder return of 245%, with market capitalisation climbing from $605 million to $2.6 billion.

From supply-chain participant to platform acquirer

The defining strategic shift in VISION 2032 is the scaling of Ducommun's M&A ambition. Where previous bolt-on acquisitions were measured in tens of millions, the new roadmap targets acquisitions in the $300 million to $500 million range, an increase in deal size of three to five times. Recent additions to the portfolio, spanning magnetic seals, ammunition handling systems, lightning protection, thermoplastic extrusions and aerodynamic systems, illustrate the direction: proprietary engineered content that commands premium pricing and is harder for prime contractors to substitute.

For the defence franchise specifically, the company projects a mid-teens compound annual growth rate through 2032 for its missile and radar businesses. That projection sits against a broader backdrop of elevated global defence budgets. NATO member states are rebuilding depleted munitions stockpiles, and the US Department of Defense is under sustained political pressure to expand domestic missile production capacity. A mid-tier supplier with existing positions on missile programmes is well placed to absorb that demand, if it can scale manufacturing fast enough.

On the commercial aviation side, the company argues it can capture narrowbody platform volume recovery with minimal incremental capital expenditure, given existing structural capacity. The implied logic is that margin expansion, rather than heavy reinvestment, will characterise the commercial segment through the plan period.

The convergence read-across: defence industrials meet capital markets

Ducommun's investor day is notable not just for its operational targets but for what it signals about the current appetite for listed defence-industrial equities. Goldman Sachs analysts, who carry a Buy rating on the stock, described the company as having "unique positions on growth verticals with A&D, missile, aero OE, aftermarket, multiple company-specific margin drivers, and an acquisition platform, all under the umbrella of company transformation." Citi noted the company "surpassed both our and consensus expectations," while RBC flagged an "impressive set of 2032 targets."

That Wall Street consensus matters beyond Ducommun's own balance sheet. The willingness of bulge-bracket analysts to back a mid-cap defence-industrial consolidator reflects a broader structural shift in how institutional capital is being allocated across the defence supply chain. As prime contractors, Lockheed, RTX, Northrop, face their own delivery pressures, the tier-two and tier-three layers are being revalued. Investors are looking for platforms that can aggregate fragmented specialty manufacturers, rationalise them, and plug them into long-cycle government contracts.

The VISION 2032 roadmap positions Ducommun squarely in that consolidator role. Whether the pipeline of $300 million to $500 million targets exists at valuations that make financial sense, and whether the acquisition integration capability can scale alongside the ambition, are the two questions cross-sector investors should be asking before the next progress update. The company's next formal checkpoint against VISION 2032 metrics is likely to be its full-year 2026 earnings call.